The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Diabetic Retinopathy
Abstract
The incidence of diabetes is increasing, but that of diabetic retinopathy is falling, probably owing to better management of glucose levels, lipid abnormalities, and hypertension. Clinical trials of VEGF and PPAR-α inhibitors are improving vision and providing insights into pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Supplementing vitamin D2 or D3 may reduce PTH in persons with CKD and secondary hyperparathyroidism.484,485”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [485]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793 · cited 1×
“Moreover, PKC- has been shown to be an integral component of cellular signaling by vascular endothelial growth factors (VEGFs) (23), important mediators of ocular neovascularization, secondary to retinal ischemia and diabetic macular edema (DME) (24,25).”
BackgroundThe Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes
Saydah, S. H. (2004) · JAMA · doi:10.1001/jama.291.3.335 · Cited by 1,357
Effects of medical therapies on retinopathy progression in type 2 diabetes
The ACCORD Study Group and ACCORD Eye Study Group (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001288 · Cited by 1,311
Adamis, A. P., Miller, J. W., Bernal, M.-T., D'Amico, D. J., Folkman, J., Yeo, T.-K., & Yeo, K.-T. (1994) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75794-0 · Cited by 1,296
Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G., & Gardner, T. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2425 · Cited by 1,295
Self-citationThe Prevalence of Diabetic Retinopathy Among Adults in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.552 · Cited by 1,148
Self-citationKeech, A., Mitchell, P., Summanen, P., O'Day, J., Davis, T., Moffitt, M., Taskinen, M.-R., Simes, R., Tse, D., Williamson, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61607-9 · Cited by 1,109
Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
Stratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019
Renal and retinal effects of enalapril and losartan in type 1 diabetes
Mauer, M., Zinman, B., Gardiner, R., Suissa, S., Sinaiko, A., Strand, T., Drummond, K., Donnelly, S., Goodyer, P., Gubler, M. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808400 · Cited by 791
Self-citationEffect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
Chaturvedi, N., Sjolie, A.-K., Stephenson, J. M., Abrahamian, H., Keipes, M., Castellarin, A., Rogulja-Pepeonik, Z., & Fuller, J. H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06209-0 · Cited by 743 · cited 2×
“The Eurodiab Controlled Trial of Lisinopril in Insulin Dependent Diabetes (EUCLID) Study Group investigated the effect of lisinopril in patients with type 1 diabetes who were normotensive and normo- or microalbuminuric (88).”
BackgroundMethod(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Patz, A., Fine, S., Finkelstein, D., Prout, T., Aiello, L., Bradley, R., Briones, J. C., Myers, F., Bresnick, G., de Venecia, G., et al. (1978) · Ophthalmology · doi:10.1016/s0161-6420(78)35693-1 · Cited by 652
Regulation of retinal blood flow in health and disease
Pournaras, C. J., Rungger-Brändle, E., Riva, C. E., Hardarson, S. H., & Stefansson, E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.02.002 · Cited by 618
(2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.06.052 · Cited by 614
Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
M. Joussen, A., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Döhmen, S., & P. Adamis, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0707fje · Cited by 567
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Nguyen, Q. D., Shah, S. M., Khwaja, A. A., Channa, R., Hatef, E., Do, D. V., Boyer, D., Heier, J. S., Abraham, P., Thach, A. B., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.08.016 · Cited by 532
Rema, M., Premkumar, S., Anitha, B., Deepa, R., Pradeepa, R., & Mohan, V. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0019 · Cited by 520
Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic Retinopathy
Watanabe, D., Suzuma, K., Matsui, S., Kurimoto, M., Kiryu, J., Kita, M., Suzuma, I., Ohashi, H., Ojima, T., Murakami, T., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041773 · Cited by 484
Chaturvedi, N., Porta, M., Klein, R., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Sjølie, A. K. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61412-9 · Cited by 451
Self-citation(1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30973-6 · Cited by 446
Sjølie, A. K., Klein, R., Porta, M., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Chaturvedi, N. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61411-7 · Cited by 435
Self-citationGeraldes, P., Hiraoka-Yamamoto, J., Matsumoto, M., Clermont, A., Leitges, M., Marette, A., Aiello, L. P., Kern, T. S., & King, G. L. (2009) · Nature Medicine · doi:10.1038/nm.2052 · Cited by 425
Aveleira, C. A., Lin, C.-M., Abcouwer, S. F., Ambrósio, A. F., & Antonetti, D. A. (2010) · Diabetes · doi:10.2337/db09-1606 · Cited by 403
Self-citationMicroglial Activation in Human Diabetic Retinopathy
Zeng, H.-Y. (2008) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2007.65 · Cited by 402
Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy
Enge, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf418 · Cited by 402
Müller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage
Wang, J., Xu, X., Elliott, M. H., Zhu, M., & Le, Y.-Z. (2010) · Diabetes · doi:10.2337/db09-1420 · Cited by 396
Demircan, N., Safran, B. G., Soylu, M., Ozcan, A. A., & Sizmaz, S. (2006) · Eye · doi:10.1038/sj.eye.6702138 · Cited by 395
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.11.1631 · Cited by 395
Joussen, A. M., Poulaki, V., Qin, W., Kirchhof, B., Mitsiades, N., Wiegand, S. J., Rudge, J., Yancopoulos, G. D., & Adamis, A. P. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64869-9 · Cited by 392
Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
Hovind, P., Tarnow, L., Rossing, K., Rossing, P., Eising, S., Larsen, N., Binder, C., & Parving, H.-H. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1258 · Cited by 376
Murakami, T., Felinski, E. A., & Antonetti, D. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016766 · Cited by 372
Self-citationvan Dijk, H. W., Kok, P. H. B., Garvin, M., Sonka, M., DeVries, J. H., Michels, R. P. J., van Velthoven, M. E. J., Schlingemann, R. O., Verbraak, F. D., & Abra`moff, M. D. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3143 · Cited by 367
Decreased Retinal Ganglion Cell Layer Thickness in Patients with Type 1 Diabetes
van Dijk, H. W., Verbraak, F. D., Kok, P. H. B., Garvin, M. K., Sonka, M., Lee, K., DeVries, J. H., Michels, R. P. J., van Velthoven, M. E. J., Schlingemann, R. O., et al. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-5041 · Cited by 359
Gao, B.-B., Clermont, A., Rook, S., Fonda, S. J., Srinivasan, V. J., Wojtkowski, M., Fujimoto, J. G., Avery, R. L., Arrigg, P. G., Bursell, S.-E., et al. (2007) · Nature Medicine · doi:10.1038/nm1534 · Cited by 357
The neurovascular unit in the setting of stroke
Del Zoppo, G. J. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02199.x · Cited by 285
Schram, M. T., Chaturvedi, N., Schalkwijk, C. G., Fuller, J. H., Stehouwer, C. D. A., & EURODIAB Prospective Complications Study Group (2005) · Diabetologia · doi:10.1007/s00125-004-1628-8 · Cited by 282
Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.032 · Cited by 276
Antonetti, D. A., Wolpert, E. B., DeMaio, L., Harhaj, N. S., & Scaduto, R. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00740.x · Cited by 272
Self-citationThe Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
Kuiper, E. J., Van Nieuwenhoven, F. A., de Smet, M. D., van Meurs, J. C., Tanck, M. W., Oliver, N., Klaassen, I., Van Noorden, C. J. F., Goldschmeding, R., & Schlingemann, R. O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002675 · Cited by 241
Müller cell‐derived VEGF is a significant contributor to retinal neovascularization
Bai, Y., Ma, J., Guo, J., Wang, J., Zhu, M., Chen, Y., & Le, Y. (2009) · The Journal of Pathology · doi:10.1002/path.2611 · Cited by 238
Harhaj, N. S., Felinski, E. A., Wolpert, E. B., Sundstrom, J. M., Gardner, T. W., & Antonetti, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0322 · Cited by 238
Self-citationNordwall, M., Bojestig, M., Arnqvist, H. J., & Ludvigsson, J. (2004) · Diabetologia · doi:10.1007/s00125-004-1431-6 · Cited by 216
Proteolytic Degradation of VE-Cadherin Alters the Blood-Retinal Barrier in Diabetes
Navaratna, D., McGuire, P. G., Menicucci, G., & Das, A. (2007) · Diabetes · doi:10.2337/db06-1694 · Cited by 211
Pearson, P. A., Comstock, T. L., Ip, M., Callanan, D., Morse, L. S., Ashton, P., Levy, B., Mann, E. S., & Eliott, D. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.048 · Cited by 207
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications
Tong, Z., Yang, Z., Patel, S., Chen, H., Gibbs, D., Yang, X., Hau, V. S., Kaminoh, Y., Harmon, J., Pearson, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800454105 · Cited by 204
Seki, M., Tanaka, T., Nawa, H., Usui, T., Fukuchi, T., Ikeda, K., Abe, H., & Takei, N. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2412 · Cited by 193
Beyond Hemoglobin A1c—Need for Additional Markers of Risk for Diabetic Microvascular Complications
Hirsch, I. B. (2010) · JAMA · doi:10.1001/jama.2010.785 · Cited by 184
The 25-Year Incidence of Visual Impairment in Type 1 Diabetes Mellitus
Klein, R., Lee, K. E., Gangnon, R. E., & Klein, B. E. K. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.06.051 · Cited by 181
Self-citationDiabetes Reduces Basal Retinal Insulin Receptor Signaling
Reiter, C. E. N., Wu, X., Sandirasegarane, L., Nakamura, M., Gilbert, K. A., Singh, R. S. J., Fort, P. E., Antonetti, D. A., & Gardner, T. W. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-0744 · Cited by 173
Self-citationWilkinson-Berka, J. L., Tan, G., Jaworski, K., Harbig, J., & Miller, A. G. (2009) · Circulation Research · doi:10.1161/circresaha.108.176008 · Cited by 172
Sultan, M. B., Zhou, D., Loftus, J., Dombi, T., & Ice, K. S. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.045 · Cited by 172
Dendrite Remodeling and Other Abnormalities in the Retinal Ganglion Cells of Ins2AkitaDiabetic Mice
Gastinger, M. J., Kunselman, A. R., Conboy, E. E., Bronson, S. K., & Barber, A. J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0683 · Cited by 170
Review: Molecular pathogenesis of blood–brain barrier breakdown in acute brain injury
Nag, S., Kapadia, A., & Stewart, D. J. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01138.x · Cited by 161
Targher, G., Bertolini, L., Chonchol, M., Rodella, S., Zoppini, G., Lippi, G., Zenari, L., & Bonora, E. (2010) · Diabetologia · doi:10.1007/s00125-010-1720-1 · Cited by 158
Effect of Ruboxistaurin in Patients With Diabetic Macular Edema
(2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.3.318 · Cited by 151
Local Multifocal Oscillatory Potential Abnormalities in Diabetes and Early Diabetic Retinopathy
Bearse, M. A., Han, Y., Schneck, M. E., Barez, S., Jacobsen, C. H., & Adams, A. J. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0308 · Cited by 133
Are Individuals With Diabetes Seeing Better?
Klein, R., & Klein, R. (2010) · Diabetes · doi:10.2337/db09-1904 · Cited by 116
Self-citationThe prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea
West, S. D., Groves, D. C., Lipinski, H., Nicoll, D., Mason, R. H., Scanlon, P. H., & Stradling, J. R. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02962.x · Cited by 115
Felinski, E. A., Cox, A. E., Phillips, B. E., & Antonetti, D. A. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.01.002 · Cited by 111
Self-citationVanGuilder, H. D., Brucklacher, R. M., Patel, K. M., Ellis, R. W., Freeman, W. M., & Barber, A. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06322.x · Cited by 111
Inflammatory, Hemostatic, and Other Novel Biomarkers for Diabetic Retinopathy
Nguyen, T. T., Alibrahim, E., Islam, A. F. M., Klein, R., Klein, B. E. K., Cotch, M. F., Shea, S., & Wong, T. Y. (2009) · Diabetes Care · doi:10.2337/dc09-0102 · Cited by 103
Self-citationSuh, D.-C., Kim, C.-M., Choi, I.-S., Plauschinat, C. A., & Barone, J. A. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832d4aee · Cited by 99
Clermont, A. C., Chilcote, T. J., Kita, T., Liu, J., Riva, P., Sinha, S., & Feener, E. P. (2011) · Diabetes · doi:10.2337/db10-1260 · Cited by 98
Altered Insulin Signaling in Retinal Tissue in Diabetic States
Kondo, T., & Kahn, C. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401339200 · Cited by 97
Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies
Wright, A. D., & Dodson, P. M. (2011) · Eye · doi:10.1038/eye.2011.62 · Cited by 75
Fort, P. E., Losiewicz, M. K., Reiter, C. E. N., Singh, R. S., Nakamura, M., Abcouwer, S. F., Barber, A. J., & Gardner, T. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026498 · Cited by 74
Self-citationArnold, E., Rivera, J. C., Thébault, S. C., Moreno-Páramo, D., Quiroz–Mercado, H., Quintanar‐Stephano, A., Binart, N., de la Escalera, G. M., & Clapp, C. (2010) · Diabetes · doi:10.2337/db10-0873 · Cited by 74
Mann, D. M. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.296 · Cited by 71
The role of Humphrey Matrix testing in the early diagnosis of retinopathy in type 1 diabetes
Parravano, M., Oddone, F., Mineo, D., Centofanti, M., Borboni, P., Lauro, R. D., Tanga, L., & Manni, G. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.143057 · Cited by 61
The influence of diabetes on glutamate metabolism in retinas
Gowda, K., Zinnanti, W. J., & LaNoue, K. F. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07206.x · Cited by 56
Rajala, R. V. S., Wiskur, B. J., Tanito, M., Callegan, M. C., & Rajala, A. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2851 · Cited by 55
Yang, J., Duh, E. J., Caldwell, R. B., & Behzadian, M. A. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2878 · Cited by 53
Rapid, Noninvasive Detection of Diabetes-Induced Retinal Metabolic Stress
Field, M. G., Elner, V. M., Puro, D. G., Feuerman, J. M., Musch, D. C., Pop‐Busui, R., Hackel, R., Heckenlively, J. R., & Petty, H. R. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.7.934 · Cited by 50
Zietz, B., Buechler, C., Kobuch, K., Neumeier, M., Schölmerich, J., & Schäffler, A. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1058086 · Cited by 47
Diabetic macular oedema and visual loss: relationship to location, severity and duration
Gardner, T. W., Larsen, M., Girach, A., Zhi, X., & on behalf of the Protein Kinase C Diabetic Retinopathy Study (PKC‐DRS2) Study Group (2009) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2009.01545.x · Cited by 46
Self-citationChanges in Incidence of Diabetes Mellitus–Related Eye Disease Among US Elderly Persons, 1994-2005
Sloan, F. A., Belsky, D., Ruiz, D., & Lee, P. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.11.1548 · Cited by 45
Harrison, W. W., Bearse, M. A., Schneck, M. E., Wolff, B. E., Jewell, N. P., Barez, S., Mick, A. B., Dolan, B. J., & Adams, A. J. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7533 · Cited by 40
Tissue plasminogen activator-mediated PDGF signaling and neurovascular coupling in stroke
Su, E. J., Fredriksson, L., Schielke, G. P., Eriksson, U., & Lawrence, D. A. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03402.x · Cited by 40
Type 2 diabetes mellitus red zone
Al-Rubeaan, K. A. (2010) · International Journal of Diabetes Mellitus · doi:10.1016/j.ijdm.2009.12.009 · Cited by 25
Retinal function in relation to improved glycaemic control in type 1 diabetes
Holfort, S. K., Nørgaard, K., Jackson, G. R., Hommel, E. E., Madsbad, S., Munch, I. C., Klemp, K., Sander, B., & Larsen, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2149-x · Cited by 22
Research works printed but not linked: 1
- Scheppke L, 2008, J Clin Invest, 118, 2337
Cited by
Optical coherence tomography angiography
Spaide, R. F., Fujimoto, J. G., Waheed, N. K., Sadda, S. R., & Staurenghi, G. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.003 · Cited by 1,779
Wong, T. Y., Cheung, C. M. G., Larsen, M., Sharma, S., & Simó, R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.12 · Cited by 1,094
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Duh, E. J., Sun, J. K., & Stitt, A. W. (2017) · JCI Insight · doi:10.1172/jci.insight.93751 · Cited by 1,057
Vascular Complications of Diabetes: Mechanisms of Injury and Protective Factors
Rask-Madsen, C., & King, G. L. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.012 · Cited by 846
Metadata
- Authors
- Antonetti, D. A., Klein, R., & Gardner, T. W.
- Affiliations
- University of Michigan (US)
- University of Wisconsin–Madison (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-03-29
- Volume
- 366
- Issue
- 13
- Pages
- 1227-1239
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4244017022
- Cited by
- 1,659
- References
- 89
- Citations by year
- 2026: 122 · 2025: 148 · 2024: 99 · 2023: 133 · 2022: 135 · 2021: 172 · 2020: 156 · 2019: 120 · 2018: 121 · 2017: 104 · 2016: 89 · 2015: 95 · 2014: 95 · 2013: 54 · 2012: 14
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
- Keywords
- diabetic retinopathy, diabetes mellitus, incidence trends, glycemic control, lipid metabolism disorders, hypertension, VEGF inhibitors, pathogenesis, visual outcome
- MeSH terms
- Diabetes Mellitus, Diabetic Retinopathy, Humans, Retina, Retinal Vessels, Incidence, Disease Progression, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.